Print Mode Enable Media Only

News chronological

10 items before 1152638 (Keyword: "medication-access" (~10 currently found))

AMERICANALMANAC (Sadie Smith) - Trump's FDA pick Heidi Overton faces confirmation fight as pro-life leaders eye mifepristone crackdown

President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to […] The post Trump's FDA pick Heidi Overton faces confirmation fight as pro-life leaders eye mifepristone crackdown appeared first on American Almanac .

President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to the FDA's handling of mifepristone, the chemical abortion drug that now accounts for roughly two-thirds of all clinician-provided abortions in the United States. Mize said he has spoken with Overton five or six times and believes she understands the risks the drug poses to women, particularly under the current rules that allow it to be prescribed after a telehealth visit and shipped by mail…Open

JUSTTHENEWS (The Center Square Staff) - Parental rights concerns raised after Illinois expands minors’ access to birth control

Gov. J.B. Pritzker signed SB 3341 into law, allowing minors to independently access contraceptive services, including receiving prescriptions and picking up contraception at pharmacies

THENATIONALPULSE (Pulse Wires) - Trump FDA Approves New Cholesterol-Lowering Pill.

The Food and Drug Administration (FDA) has approved a new pill that lowers cholesterol.

The Food and Drug Administration has approved a cholesterol-lowering daily pill called Lipfendra, expanding treatment possibilities beyond statins and injectables. PULSE POINTS WHAT HAPPENED: - DETAIL: On Thursday, the FDA approved Lipfendra , a new cholesterol-lowering pill. Developed by Merck, a German pharmaceutical multinational, Lipfendra belongs to the PCSK9 inhibitor class of medications. PCSK9 is a liver-produced enzyme that regulates blood cholesterol levels. The pill is the first of its kind, as previous PCSK9 inhibitors were only available as injections. The pill is designed to be taken daily. Lipfendra is intended to help patients with hypercholesterolemia, or high LDL, known widely as “bad” cholesterol. According to…Open

NEWSNATIONNOW (Patrick Djordjevic) - GLP-1 drugs available for $50 a month under Medicare pilot

Medicare's “GLP-1 Bridge Program” will allow certain enrollees to receive coverage for select medications.

NYTIMES (Pam Belluck and Sheryl Gay Stolberg) - Abortion Pill Lawsuit Leaves Trump Silent, and in a Political Bind

Louisiana wants the Food and Drug Administration to curtail access to the medication. Doing so could cost Republicans at the polls.

THEFEDERALIST (Jordan Boyd) - As Makary Steps Down, Pro-Lifers Await Movement From Trump FDA On Abortion Drugs

Makary’s departure will prove to be a pivotal point for pro-lifers who want to see the administration take action on abortion pills.

NPR (Andrew Jones) - Natural disasters can cause another crisis for those recovering from opioid addiction

People recovering from opioid addiction risk relapse when they can't get their medications after natural disasters. A group of doctors is calling for lawmakers to ease access to the meds.

THEFEDERALIST (Jordan Boyd) - Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women

The FDA appears to be slow-walking its mifepristone review, frustrating Trump allies in both Congress and pro-life states.

JUSTTHENEWS (Greg Piper) - GOP states unite against Trump FDA for violating their pro-life laws with lax abortion pill rules

21 states, 60 members of Congress, abortion coercion victims and researchers back Louisiana against Trump administration, which is reviewing mifepristone's safety with no end date in sight.

THEFEDERALIST (Jordan Boyd) - FDA Wants Pause On Landmark Abortion Pill Suit. Pro-Lifers Say It Will Cost Lives

The FDA hinted it does not plan to weigh on the safeguards stripped under Biden until its mifepristone review is complete.